Saturday, October 24, 2015 Cincinnati, Ohio
Faculty

Symposium Director

Henry A. Nasrallah, MD
The Sydney W. Souers Professor and Chair
Department of Neurology and Psychiatry
Saint Louis University School of Medicine
St. Louis, Missouri
Dr. Henry Nasrallah is professor and chairman of the Department of Neurology and Psychiatry at Saint Louis University, and holds the Sydney W. Souers Endowed Chair. He is a widely recognized neuropsychiatrist, educator and researcher. Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as chair of the Ohio State University Department of Psychiatry for twelve years. In January 2003, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience. In October 2013, he joined St. Louis University to chair the integrated Department of Neurology and Psychiatry.
Dr. Nasrallah's research focuses on the neurobiology and psychopharmacology of schizophrenia and related psychoses. He has published 380 scientific articles, 440 abstracts, as well as 11 books. He is Editor-In-Chief of two journals (SCHIZOPHRENIA RESEARCH and CURRENT PSYCHIATRY) and is the co-founder of the Schizophrenia International Research Society (SIRS). He is board certified in in adult psychiatry. He is a fellow in the American College of Neurpsychopharmacology (ACNP) a distinguished fellow of the American Psychiatric Association (APA) , and has served as president of the Cincinnati Psychiatric Society and as president of the American Academy of Clinical Psychiatrists. He has twice received the NAMI Exemplary Psychiatrist Award and was chosen as the U.S.A. Teacher of the Year by the Psychiatric Times. He has received over 90 research grants and is listed in all editions of the book "Best Doctors in America".

2015 Faculty

Leslie Citrome, MD
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, NY
Leslie Citrome, MD, MPH, is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York and has a private practice in Pomona, New York. He is a member of the Board of Directors of the American Society of Clinical Psychopharmacology and the Mental Health Association of Rockland County. Dr Citrome was the Founding Director of the Clinical Research and Evaluation Facility at the Nathan S Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly 2 decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr Citrome is now engaged as a consultant in clinical trial design and interpretation. He is a frequent lecturer on the quantitative assessment of clinical trial results using evidence-based medicine. Dr Citrome graduated from the McGill University Faculty of Medicine and completed a residency and chief residency in psychiatry at New York University. His primary research interests have centered on psychopharmacologic approaches to schizophrenia, bipolar disorder, major depressive disorder, the management of treatment-refractory schizophrenia, and the management of aggressive and violent behavior. Dr Citrome has authored or coauthored more than 400 research reports, reviews, chapters, and abstracts in the scientific literature. He serves as Editor-in-Chief for the International Journal of Clinical Practice and is on the editorial board of 9 other medical journals. He has lectured extensively throughout the United States, Canada, Europe, and Asia. Dr Citrome is the author of the book, Handbook of Treatment-Resistant Schizophrenia, published in 2013 by Springer Healthcare.
Paula J. Clayton, MD
Emeritus Faculty
Department of Psychiatry and Behavioral Sciences
University of New Mexico School of Medicine
Albuquerque, NM
Past Medical Director
American Foundation for Suicide Prevention
New York, NY
Paula J. Clayton, a native of St. Louis, received her undergraduate degree from the University of Michigan in 1956. She was one of four women to earn a medical degree from the Washington University School of Medicine in 1960. After an internship at St. Luke's Hospital, Clayton was a resident in Psychiatry at Barnes and Renard Hospitals in St. Louis, serving as chief resident in 1964-65. In 1965 Clayton was appointed an instructor in Psychiatry at Washington University. She was promoted to assistant professor in 1967, to associate professor in 1972, and finally to full professor in 1974.

An internationally recognized researcher in psychiatry, Clayton became known for her studies on mood disorders and bereavement. She was the first to define mania and schizoaffective disorders. In 1967 Clayton and her mentor, George Winokur, were the first Americans to describe the separation of mood disorders into unipolar and bipolar illnesses. In the late 1960s and early 1970s, Clayton published landmark research on the symptoms and normal course of bereavement. Clayton co-authored the first textbook on mania, Manic Depressive Illness, in 1969. Her publications to date include over 160 papers, three additional books, and 20 book chapters.

In 1980 Clayton left Washington University to head the Department of Psychiatry at the University of Minnesota School of Medicine, thus becoming the first woman to chair a department of psychiatry in the U.S. and the first woman to head a department in the medical school of the University of Minnesota. After almost 20 years in Minnesota, Clayton retired as professor emeritus of Psychiatry. She then joined the faculty of the University of New Mexico School of Medicine, where she is currently a professor of Psychiatry.

Dr. Clayton has been an active member and leader of many psychiatric societies, including the American Psychiatric Association and the American College of Neuropsychopharmacology. She has served as president of the Psychiatric Research Society (1977-78), the American Psychopathological Association (1981), and the Society of Biological Psychiatry (1986-87).

In 1985 Clayton received the Athena Award from the University of Michigan as the outstanding alumna of the year. That same year she received a Distinguished Alumnae Award from Washington University. Dr. Clayton received a Lifetime Research Award from the National Depressive and Manic Depressive Association. In 1993, Clayton was one of eight women honored with the Aphrodite Jannopoulo Hofsommer Award from Washington University.
Jason I. Dailey, MD, FAPA
Major
Medical Corps, US Army
Commander, 212th Medical Detachment (COSC)
Fort Campbell, KY
Dr. Jason Dailey is a US Army psychiatrist, and currently serves as the Commander of the 212th Medical Detachment (Combat and Operational Stress Control) at Ft. Campbell, KY. He trained at UCLA and the University of Michigan Medical School prior to beginning active duty service with the US Army and completing his psychiatry residency at Tripler Army Medical Center, Hawaii. He is a board-certified Diplomat of the American Board of Psychiatry and Neurology and a Fellow of the American Psychiatric Association.

Dr. Dailey is also a combat veteran having deployed to Afghanistan as the Command Psychiatrist for Regional Command- East, Afghanistan. As the Division Psychiatrist for the 101st Airborne Division (Air Assault) he was responsible for the supervision and mentorship of psychologists and social workers throughout the Division, and regularly lectured primary care physicians and mid-level providers on psychotropic prescribing. His unique experience as both the Commander of a deployable psychiatric unit and as a staff officer in charge of behavioral health care for eastern Afghanistan makes him one of the US Army's top subject matter experts in the provision of psychiatric services in a combat zone. His military decorations include the Meritorious Service Medal, the Army Commendation Medal, the Army Achievement Medal, and the Air Assault Badge.
Marlene Freeman, MD
Associate Professor of Psychiatry, Harvard Medical School
Medical Director, CTNI
Director of Clinical Services, Perinatal and Reproductive
Psychiatry Program
Massachusetts General Hospital
Marlene P. Freeman, MD is an Associate Professor of Psychiatry, Harvard Medical School.

She is the Director of Clinical Services, Perinatal and Reproductive Psychiatry Program at Massachusetts General Hospital and the Medical Director of the MGH Clinical Trials Network and Institute.

Dr. Freeman completed medical school at Northwestern University Medical School. She completed residency at the Harvard Longwood Psychiatry Residency Program and a research fellowship in the Biological Psychiatry Program at the University of Cincinnati College of Medicine. Her research and clinical expertise is in the areas of mood disorders and women's mental health. She previously established and directed Women's Mental Health Programs at the University of Arizona and the University of Texas Southwestern Medical Center. She is the Director of Clinical Services at the MGH Center for Women's Mental Health, Perinatal and Reproductive Psychiatry. She is Vice Editor-in-Chief for The Journal of Clinical Psychiatry. She is a Distinguished Fellow of the American Psychiatric Association (APA), and chaired the APA Task Force on Complementary and Alternative Medicine, subcommittee on Omega-3 Fatty Acids in Psychiatry, and was a member of the APA's workgroup on Major Depressive Disorder treatment guidelines. She is on the Board of Directors of the American Society of Clinical Psychopharmacology (ASCP) and Postpartum Progress, Inc., and is a Member of the American College of Neuropsychopharmacology (ACNP). She is a Member of the Veterans Administration Reproductive Mental Health Steering Committee.
Jeffrey Strawn, MD
Assistant Professor of Psychiatry
Department of Psychiatry & Behavioral Neuroscience
University of Cincinnati
Cincinnati, OH
Jeffrey R. Strawn, MD, FAACAP, is Assistant Professor of Psychiatry and Pediatrics at the University of Cincinnati and Cincinnati Children's Hospital Medical Center. Originally from Kentucky, Dr. Strawn earned a bachelor's degree in biology from the University of Kentucky and went on to earn his M.D. from the University of Cincinnati, College of Medicine. He completed his psychiatric residency training at UC and a clinical fellowship in child and adolescent psychiatry at Cincinnati Children's. He has board certification in general, as well as child and adolescent, psychiatry.
Rajiv Tandon, MD
Chief of Psychiatry
Program of Mental Health
State of Florida Department of Children and Families
Gainesville, FL
Rajiv Tandon, MD, is the Chief of Psychiatry in the Program of Mental Health at the State of Florida Department of Children and Families. Formerly, he was promoted to Associate Professor, given Tenure and rose to Professor at the Department of Psychiatry in the University of Michigan Medical Center, Ann Arbor, from 1987-2004. In addition to his medical degree, he has a Master's degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health and a diploma in Business Administration from the Harvard University Business School. At the University of Michigan, he developed the clinical and research Schizophrenia Program, which was the sixth most published schizophrenia program in the world in the 1990's.

Additionally, he held a variety of administrative responsibilities, including directing the Hospital Services Division (inpatient, consultation-liaison, and emergency psychiatry) and Division of Community Psychiatry from 1996-2000. From 1993-1996, he was the Director of the Adult Inpatient Psychiatry Program and the electroconvulsive Therapy (ECT) Program. At the University of Michigan Medical Center, his clinical responsibilities were primarily on the adult inpatient unit, which he directed from 1993-1996. His research focus has been the psychopathology and neurobiology of schizophrenia. Since 2000, he has been a member of the Scientific Council of the National Alliance for the Mentally Ill and on the Board of Directors of the National Schizophrenia Foundation (Chair 2002-2005).

Dr. Tandon has authored more than 250 scientific publications, and given over 600 national and international scientific presentations. He has received several awards for research and teaching in schizophrenia, including the American Psychiatric Association Young Psychiatrist Researcher of the Year award in 1993 and the a1997 Future Psych award for outstanding achievement in schizophrenia research. He has been included in every edition of THE BEST DOCTORS IN AMERICA since 1995. His principal areas of research interest include psychopharmacology of schizophrenia and neurobiology of schizophrenia. He is a member of the NASMHPD Medical Directors' Board, a member of the World Psychiatric Association Section on Pharmacopsychiatry, and a member of the DSM-V workgroup on psychotic disorders. He is also a member of the editorial boards of several journals. He has been a member of several NIH study sections over his career.

In his capacity Chief of Psychiatry in the Office of Mental Health in the Department of Children and Families, he has participated in the development of a number of innovative programs. He was a member of the Blueprint Commission on Juvenile Justice as also a member of the Supreme Court Subcommittee on Criminal Justice and Mental Health (Leifman committee). He has been intimately involved in the development of a range of evidence-based psychopharmacology programs both in the hospital-based and community settings. He has over 25 years of experience in the evaluation and treatment of psychiatric patients, as national expert, researcher, and mentor.